nodes	percent_of_prediction	percent_of_DWPC	metapath
Zanamivir—Lymphopenia—Mechlorethamine—lymphatic system cancer	0.0449	0.0449	CcSEcCtD
Zanamivir—Haemoglobin—Mechlorethamine—lymphatic system cancer	0.0116	0.0116	CcSEcCtD
Zanamivir—Haemorrhage—Mechlorethamine—lymphatic system cancer	0.0115	0.0115	CcSEcCtD
Zanamivir—Erythema multiforme—Mechlorethamine—lymphatic system cancer	0.0109	0.0109	CcSEcCtD
Zanamivir—Bronchospasm—Teniposide—lymphatic system cancer	0.0105	0.0105	CcSEcCtD
Zanamivir—Dehydration—Fludarabine—lymphatic system cancer	0.0101	0.0101	CcSEcCtD
Zanamivir—Neutropenia—Teniposide—lymphatic system cancer	0.00995	0.00995	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Fludarabine—lymphatic system cancer	0.00974	0.00974	CcSEcCtD
Zanamivir—Musculoskeletal pain—Vincristine—lymphatic system cancer	0.00921	0.00921	CcSEcCtD
Zanamivir—Bronchitis—Fludarabine—lymphatic system cancer	0.00899	0.00899	CcSEcCtD
Zanamivir—Neutropenia—Fludarabine—lymphatic system cancer	0.00874	0.00874	CcSEcCtD
Zanamivir—Haemoglobin—Teniposide—lymphatic system cancer	0.00856	0.00856	CcSEcCtD
Zanamivir—Haemorrhage—Teniposide—lymphatic system cancer	0.00851	0.00851	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Mechlorethamine—lymphatic system cancer	0.0085	0.0085	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Fludarabine—lymphatic system cancer	0.00826	0.00826	CcSEcCtD
Zanamivir—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00821	0.00821	CcSEcCtD
Zanamivir—Infection—Mechlorethamine—lymphatic system cancer	0.00815	0.00815	CcSEcCtD
Zanamivir—Skin disorder—Mechlorethamine—lymphatic system cancer	0.00797	0.00797	CcSEcCtD
Zanamivir—Anorexia—Mechlorethamine—lymphatic system cancer	0.00782	0.00782	CcSEcCtD
Zanamivir—Sinusitis—Fludarabine—lymphatic system cancer	0.00782	0.00782	CcSEcCtD
Zanamivir—Chills—Teniposide—lymphatic system cancer	0.00764	0.00764	CcSEcCtD
Zanamivir—Arrhythmia—Teniposide—lymphatic system cancer	0.00761	0.00761	CcSEcCtD
Zanamivir—Haemoglobin—Fludarabine—lymphatic system cancer	0.00752	0.00752	CcSEcCtD
Zanamivir—Haemorrhage—Fludarabine—lymphatic system cancer	0.00748	0.00748	CcSEcCtD
Zanamivir—Decreased appetite—Mechlorethamine—lymphatic system cancer	0.00713	0.00713	CcSEcCtD
Zanamivir—Erythema multiforme—Fludarabine—lymphatic system cancer	0.00708	0.00708	CcSEcCtD
Zanamivir—Agitation—Teniposide—lymphatic system cancer	0.00681	0.00681	CcSEcCtD
Zanamivir—Bronchospasm—Bleomycin—lymphatic system cancer	0.00674	0.00674	CcSEcCtD
Zanamivir—Chills—Fludarabine—lymphatic system cancer	0.00671	0.00671	CcSEcCtD
Zanamivir—Arrhythmia—Fludarabine—lymphatic system cancer	0.00669	0.00669	CcSEcCtD
Zanamivir—Face oedema—Carmustine—lymphatic system cancer	0.00668	0.00668	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00665	0.00665	CcSEcCtD
Zanamivir—Lung disorder—Methotrexate—lymphatic system cancer	0.00624	0.00624	CcSEcCtD
Zanamivir—Dehydration—Vincristine—lymphatic system cancer	0.00615	0.00615	CcSEcCtD
Zanamivir—Confusional state—Teniposide—lymphatic system cancer	0.0061	0.0061	CcSEcCtD
Zanamivir—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00605	0.00605	CcSEcCtD
Zanamivir—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00604	0.00604	CcSEcCtD
Zanamivir—Infection—Teniposide—lymphatic system cancer	0.00601	0.00601	CcSEcCtD
Zanamivir—Agitation—Fludarabine—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Zanamivir—Dehydration—Mitoxantrone—lymphatic system cancer	0.00599	0.00599	CcSEcCtD
Zanamivir—Malaise—Fludarabine—lymphatic system cancer	0.00587	0.00587	CcSEcCtD
Zanamivir—Anorexia—Teniposide—lymphatic system cancer	0.00577	0.00577	CcSEcCtD
Zanamivir—Cough—Fludarabine—lymphatic system cancer	0.00568	0.00568	CcSEcCtD
Zanamivir—Convulsion—Fludarabine—lymphatic system cancer	0.00564	0.00564	CcSEcCtD
Zanamivir—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00561	0.00561	CcSEcCtD
Zanamivir—Neutropenia—Carmustine—lymphatic system cancer	0.0056	0.0056	CcSEcCtD
Zanamivir—Arthralgia—Fludarabine—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Zanamivir—Myalgia—Fludarabine—lymphatic system cancer	0.00555	0.00555	CcSEcCtD
Zanamivir—Haemoglobin—Bleomycin—lymphatic system cancer	0.00551	0.00551	CcSEcCtD
Zanamivir—Haemorrhage—Bleomycin—lymphatic system cancer	0.00549	0.00549	CcSEcCtD
Zanamivir—Discomfort—Fludarabine—lymphatic system cancer	0.00548	0.00548	CcSEcCtD
Zanamivir—Dyspnoea—Teniposide—lymphatic system cancer	0.00539	0.00539	CcSEcCtD
Zanamivir—Confusional state—Fludarabine—lymphatic system cancer	0.00536	0.00536	CcSEcCtD
Zanamivir—Neutropenia—Vincristine—lymphatic system cancer	0.00534	0.00534	CcSEcCtD
Zanamivir—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.00532	0.00532	CcSEcCtD
Zanamivir—Infection—Fludarabine—lymphatic system cancer	0.00528	0.00528	CcSEcCtD
Zanamivir—Decreased appetite—Teniposide—lymphatic system cancer	0.00526	0.00526	CcSEcCtD
Zanamivir—Vomiting—Mechlorethamine—lymphatic system cancer	0.00522	0.00522	CcSEcCtD
Zanamivir—Neutropenia—Mitoxantrone—lymphatic system cancer	0.0052	0.0052	CcSEcCtD
Zanamivir—Rash—Mechlorethamine—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Zanamivir—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00517	0.00517	CcSEcCtD
Zanamivir—Anorexia—Fludarabine—lymphatic system cancer	0.00507	0.00507	CcSEcCtD
Zanamivir—Feeling abnormal—Teniposide—lymphatic system cancer	0.00498	0.00498	CcSEcCtD
Zanamivir—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00495	0.00495	CcSEcCtD
Zanamivir—Chills—Bleomycin—lymphatic system cancer	0.00492	0.00492	CcSEcCtD
Zanamivir—Nausea—Mechlorethamine—lymphatic system cancer	0.00487	0.00487	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00484	0.00484	CcSEcCtD
Zanamivir—Haemoglobin—Carmustine—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Zanamivir—Urticaria—Teniposide—lymphatic system cancer	0.00481	0.00481	CcSEcCtD
Zanamivir—Haemorrhage—Carmustine—lymphatic system cancer	0.00479	0.00479	CcSEcCtD
Zanamivir—Abdominal pain—Teniposide—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Zanamivir—Body temperature increased—Teniposide—lymphatic system cancer	0.00478	0.00478	CcSEcCtD
Zanamivir—Hallucination—Carmustine—lymphatic system cancer	0.00477	0.00477	CcSEcCtD
Zanamivir—Dyspnoea—Fludarabine—lymphatic system cancer	0.00474	0.00474	CcSEcCtD
Zanamivir—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00465	0.00465	CcSEcCtD
Zanamivir—Decreased appetite—Fludarabine—lymphatic system cancer	0.00462	0.00462	CcSEcCtD
Zanamivir—Fatigue—Fludarabine—lymphatic system cancer	0.00458	0.00458	CcSEcCtD
Zanamivir—Hallucination—Vincristine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Zanamivir—Pain—Fludarabine—lymphatic system cancer	0.00455	0.00455	CcSEcCtD
Zanamivir—Haemoglobin—Mitoxantrone—lymphatic system cancer	0.00448	0.00448	CcSEcCtD
Zanamivir—Hypersensitivity—Teniposide—lymphatic system cancer	0.00446	0.00446	CcSEcCtD
Zanamivir—Haemorrhage—Mitoxantrone—lymphatic system cancer	0.00445	0.00445	CcSEcCtD
Zanamivir—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00443	0.00443	CcSEcCtD
Zanamivir—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00438	0.00438	CcSEcCtD
Zanamivir—Asthenia—Teniposide—lymphatic system cancer	0.00434	0.00434	CcSEcCtD
Zanamivir—Malaise—Bleomycin—lymphatic system cancer	0.00431	0.00431	CcSEcCtD
Zanamivir—Arrhythmia—Carmustine—lymphatic system cancer	0.00428	0.00428	CcSEcCtD
Zanamivir—Body temperature increased—Fludarabine—lymphatic system cancer	0.0042	0.0042	CcSEcCtD
Zanamivir—Cough—Bleomycin—lymphatic system cancer	0.00417	0.00417	CcSEcCtD
Zanamivir—Diarrhoea—Teniposide—lymphatic system cancer	0.00414	0.00414	CcSEcCtD
Zanamivir—Myalgia—Bleomycin—lymphatic system cancer	0.00407	0.00407	CcSEcCtD
Zanamivir—Discomfort—Bleomycin—lymphatic system cancer	0.00402	0.00402	CcSEcCtD
Zanamivir—Chills—Mitoxantrone—lymphatic system cancer	0.004	0.004	CcSEcCtD
Zanamivir—Arrhythmia—Mitoxantrone—lymphatic system cancer	0.00398	0.00398	CcSEcCtD
Zanamivir—Confusional state—Bleomycin—lymphatic system cancer	0.00393	0.00393	CcSEcCtD
Zanamivir—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00392	0.00392	CcSEcCtD
Zanamivir—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.0039	0.0039	CcSEcCtD
Zanamivir—Infection—Bleomycin—lymphatic system cancer	0.00387	0.00387	CcSEcCtD
Zanamivir—Vomiting—Teniposide—lymphatic system cancer	0.00385	0.00385	CcSEcCtD
Zanamivir—Agitation—Carmustine—lymphatic system cancer	0.00383	0.00383	CcSEcCtD
Zanamivir—Asthenia—Fludarabine—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Zanamivir—Rash—Teniposide—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Zanamivir—Dermatitis—Teniposide—lymphatic system cancer	0.00381	0.00381	CcSEcCtD
Zanamivir—Headache—Teniposide—lymphatic system cancer	0.00379	0.00379	CcSEcCtD
Zanamivir—Anorexia—Bleomycin—lymphatic system cancer	0.00372	0.00372	CcSEcCtD
Zanamivir—Agitation—Vincristine—lymphatic system cancer	0.00366	0.00366	CcSEcCtD
Zanamivir—Diarrhoea—Fludarabine—lymphatic system cancer	0.00364	0.00364	CcSEcCtD
Zanamivir—Convulsion—Carmustine—lymphatic system cancer	0.00361	0.00361	CcSEcCtD
Zanamivir—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.0036	0.0036	CcSEcCtD
Zanamivir—Nausea—Teniposide—lymphatic system cancer	0.00359	0.00359	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Zanamivir—Myalgia—Carmustine—lymphatic system cancer	0.00355	0.00355	CcSEcCtD
Zanamivir—Anxiety—Carmustine—lymphatic system cancer	0.00354	0.00354	CcSEcCtD
Zanamivir—Malaise—Mitoxantrone—lymphatic system cancer	0.0035	0.0035	CcSEcCtD
Zanamivir—Dyspnoea—Bleomycin—lymphatic system cancer	0.00348	0.00348	CcSEcCtD
Zanamivir—Convulsion—Vincristine—lymphatic system cancer	0.00345	0.00345	CcSEcCtD
Zanamivir—Confusional state—Carmustine—lymphatic system cancer	0.00343	0.00343	CcSEcCtD
Zanamivir—Decreased appetite—Bleomycin—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Zanamivir—Myalgia—Vincristine—lymphatic system cancer	0.00339	0.00339	CcSEcCtD
Zanamivir—Cough—Mitoxantrone—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Zanamivir—Infection—Carmustine—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Zanamivir—Vomiting—Fludarabine—lymphatic system cancer	0.00338	0.00338	CcSEcCtD
Zanamivir—Convulsion—Mitoxantrone—lymphatic system cancer	0.00336	0.00336	CcSEcCtD
Zanamivir—Rash—Fludarabine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Zanamivir—Dermatitis—Fludarabine—lymphatic system cancer	0.00335	0.00335	CcSEcCtD
Zanamivir—Pain—Bleomycin—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Zanamivir—Headache—Fludarabine—lymphatic system cancer	0.00333	0.00333	CcSEcCtD
Zanamivir—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00331	0.00331	CcSEcCtD
Zanamivir—Arthralgia—Mitoxantrone—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Zanamivir—Myalgia—Mitoxantrone—lymphatic system cancer	0.0033	0.0033	CcSEcCtD
Zanamivir—Anxiety—Mitoxantrone—lymphatic system cancer	0.00329	0.00329	CcSEcCtD
Zanamivir—Discomfort—Mitoxantrone—lymphatic system cancer	0.00326	0.00326	CcSEcCtD
Zanamivir—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00325	0.00325	CcSEcCtD
Zanamivir—Anorexia—Carmustine—lymphatic system cancer	0.00324	0.00324	CcSEcCtD
Zanamivir—Infection—Vincristine—lymphatic system cancer	0.00323	0.00323	CcSEcCtD
Zanamivir—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00321	0.00321	CcSEcCtD
Zanamivir—Confusional state—Mitoxantrone—lymphatic system cancer	0.00319	0.00319	CcSEcCtD
Zanamivir—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Zanamivir—Nausea—Fludarabine—lymphatic system cancer	0.00316	0.00316	CcSEcCtD
Zanamivir—Infection—Mitoxantrone—lymphatic system cancer	0.00314	0.00314	CcSEcCtD
Zanamivir—Shock—Mitoxantrone—lymphatic system cancer	0.00311	0.00311	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Zanamivir—Urticaria—Bleomycin—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Zanamivir—Anorexia—Vincristine—lymphatic system cancer	0.0031	0.0031	CcSEcCtD
Zanamivir—Body temperature increased—Bleomycin—lymphatic system cancer	0.00308	0.00308	CcSEcCtD
Zanamivir—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00307	0.00307	CcSEcCtD
Zanamivir—Dyspnoea—Carmustine—lymphatic system cancer	0.00303	0.00303	CcSEcCtD
Zanamivir—Anorexia—Mitoxantrone—lymphatic system cancer	0.00302	0.00302	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Zanamivir—Decreased appetite—Carmustine—lymphatic system cancer	0.00296	0.00296	CcSEcCtD
Zanamivir—Pain—Carmustine—lymphatic system cancer	0.00291	0.00291	CcSEcCtD
Zanamivir—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00289	0.00289	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00288	0.00288	CcSEcCtD
Zanamivir—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00287	0.00287	CcSEcCtD
Zanamivir—Decreased appetite—Vincristine—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Zanamivir—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00282	0.00282	CcSEcCtD
Zanamivir—Feeling abnormal—Carmustine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Zanamivir—Fatigue—Vincristine—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Zanamivir—Asthenia—Bleomycin—lymphatic system cancer	0.0028	0.0028	CcSEcCtD
Zanamivir—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Zanamivir—Pain—Vincristine—lymphatic system cancer	0.00278	0.00278	CcSEcCtD
Zanamivir—Asthma—Methotrexate—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Zanamivir—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00275	0.00275	CcSEcCtD
Zanamivir—Fatigue—Mitoxantrone—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Zanamivir—Pain—Mitoxantrone—lymphatic system cancer	0.00271	0.00271	CcSEcCtD
Zanamivir—Abdominal pain—Carmustine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Body temperature increased—Carmustine—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Zanamivir—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00266	0.00266	CcSEcCtD
Zanamivir—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00261	0.00261	CcSEcCtD
Zanamivir—Neutropenia—Methotrexate—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00259	0.00259	CcSEcCtD
Zanamivir—Abdominal pain—Vincristine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Zanamivir—Body temperature increased—Vincristine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Zanamivir—Urticaria—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Hypersensitivity—Carmustine—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Zanamivir—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Zanamivir—Vomiting—Bleomycin—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Zanamivir—Rash—Bleomycin—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Dermatitis—Bleomycin—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Zanamivir—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00245	0.00245	CcSEcCtD
Zanamivir—Asthenia—Carmustine—lymphatic system cancer	0.00244	0.00244	CcSEcCtD
Zanamivir—Hypersensitivity—Vincristine—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Zanamivir—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Asthenia—Vincristine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Diarrhoea—Carmustine—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Zanamivir—Nausea—Bleomycin—lymphatic system cancer	0.00232	0.00232	CcSEcCtD
Zanamivir—Asthenia—Mitoxantrone—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Zanamivir—Dizziness—Carmustine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Zanamivir—Haemoglobin—Methotrexate—lymphatic system cancer	0.00223	0.00223	CcSEcCtD
Zanamivir—Diarrhoea—Vincristine—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Zanamivir—Haemorrhage—Methotrexate—lymphatic system cancer	0.00222	0.00222	CcSEcCtD
Zanamivir—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Vomiting—Carmustine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Zanamivir—Dizziness—Vincristine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Zanamivir—Rash—Carmustine—lymphatic system cancer	0.00215	0.00215	CcSEcCtD
Zanamivir—Dermatitis—Carmustine—lymphatic system cancer	0.00214	0.00214	CcSEcCtD
Zanamivir—Headache—Carmustine—lymphatic system cancer	0.00213	0.00213	CcSEcCtD
Zanamivir—Erythema multiforme—Methotrexate—lymphatic system cancer	0.0021	0.0021	CcSEcCtD
Zanamivir—Vomiting—Vincristine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Zanamivir—Rash—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Zanamivir—Dermatitis—Vincristine—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Zanamivir—Headache—Vincristine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Zanamivir—Nausea—Carmustine—lymphatic system cancer	0.00202	0.00202	CcSEcCtD
Zanamivir—Vomiting—Mitoxantrone—lymphatic system cancer	0.00201	0.00201	CcSEcCtD
Zanamivir—Rash—Mitoxantrone—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Chills—Methotrexate—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Zanamivir—Headache—Mitoxantrone—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Zanamivir—Nausea—Vincristine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Zanamivir—Nausea—Mitoxantrone—lymphatic system cancer	0.00188	0.00188	CcSEcCtD
Zanamivir—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.00179	0.00179	CcSEcCtD
Zanamivir—Malaise—Methotrexate—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Zanamivir—Cough—Methotrexate—lymphatic system cancer	0.00169	0.00169	CcSEcCtD
Zanamivir—Convulsion—Methotrexate—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Zanamivir—Arthralgia—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Myalgia—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Zanamivir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Zanamivir—Discomfort—Methotrexate—lymphatic system cancer	0.00162	0.00162	CcSEcCtD
Zanamivir—Confusional state—Methotrexate—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Zanamivir—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Zanamivir—Infection—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Zanamivir—Skin disorder—Methotrexate—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Zanamivir—Anorexia—Methotrexate—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Zanamivir—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Zanamivir—Dyspnoea—Methotrexate—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Zanamivir—Decreased appetite—Methotrexate—lymphatic system cancer	0.00137	0.00137	CcSEcCtD
Zanamivir—Fatigue—Methotrexate—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Zanamivir—Pain—Methotrexate—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Zanamivir—Feeling abnormal—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Zanamivir—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Zanamivir—Urticaria—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Abdominal pain—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Body temperature increased—Methotrexate—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Zanamivir—Hypersensitivity—Methotrexate—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Zanamivir—Asthenia—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Zanamivir—Diarrhoea—Methotrexate—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Zanamivir—Dizziness—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Zanamivir—Vomiting—Methotrexate—lymphatic system cancer	0.001	0.001	CcSEcCtD
Zanamivir—Rash—Methotrexate—lymphatic system cancer	0.000994	0.000994	CcSEcCtD
Zanamivir—Dermatitis—Methotrexate—lymphatic system cancer	0.000993	0.000993	CcSEcCtD
Zanamivir—Headache—Methotrexate—lymphatic system cancer	0.000987	0.000987	CcSEcCtD
Zanamivir—Nausea—Methotrexate—lymphatic system cancer	0.000936	0.000936	CcSEcCtD
